Antibiotic-induced lipopolysaccharide (LPS) release from Salmonella typhi: Delay between killing by ceftazidime and imipenem and release of LPS

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 4, 1998, Pages 739-743

  Van Langevelde, Petra ^a   Kwappenberg, Kitty M C ^a   Groeneveld, Paul H P ^a   Mattie, Herman ^a   Van Dissel, Jaap T ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; IMIPENEM; LIPOPOLYSACCHARIDE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL MEMBRANE; DISEASE SEVERITY; GRAM NEGATIVE BACTERIUM; PRIORITY JOURNAL; SALMONELLA TYPHI; SPHEROPLAST;

EID: 0031956681     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.4.739     Document Type: Article

References (24)

1. Acar, J. F., and F. W. Goldstein. 1996. Dilution in agar, p. 28-32. In V. Lorian (ed.), Antibiotics in laboratory medicine, 4th ed. The Williams & Wilkins Co., Baltimore, Md.
2. Bone, R. C. 1991. The pathogenesis of sepsis. Ann. Intern. Med. 115:457-469.
3. Brockmeier, D. 1984. In vitro-in vivo correlation, a time scaling problem? Arzneim. Forsch./Drug. Res. 34:1604-1607.
4. Dofferhoff, A. S. M., J. H. Nijland, H. G. de Vries-Hospers, P. O. M. Mulder, J. Weits, and V. J. J. Bom. 1991. Effects of different types and combinations of antimicrobial agents on endotoxin release from gram-negative bacteria: an in-vitro and in-vivo study. Scand. J. Infect. Dis. 23:745-754.
5. Evans, M. E., and M. Pollack. 1993. Effects of antibiotic class and concentration on the release of lipopolysaccharide from Escherichia coli. J. Infect. Dis. 167:1336-1343.
6. 51Cr-endotoxin from bacteria as an assay of serum bactericidal activity. J. Immunol. 112:2184-2192.
7. Germanier, R., and E. Furer. 1975. Isolation and characterization of galE mutant Ty 21A of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine. J. Infect. Dis. 131:553.
8. Hopkin, B. D. A. 1978. Frapper fort ou doucement: a gram-negative dilemma. Lancet ii:1193-1194.
9. Hurley, J. C. 1992. Antibiotic-induced release of endotoxin: a reappraisal. Clin. Infect. Dis. 15:840-854.
10. Hurley, J. C., W. J. Louis, F. A. Tosolini, and J. B. Carlin. 1991. Antibiotic-induced release of endotoxin in chronically bacteriuric patients. Antimicrob. Agents Chemother. 35:2388-2394.
11. Jackson, J. J., and H. Kropp. 1992. β-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP)2-specific imipenem and PBP3-specific ceftazidime. J. Infect. Dis. 165:1033-1041.
12. Mattie, H., L.-C. Zhang, E. van Strijen, B. R. Sekh, and A. E. A. Douwes-Idema. 1997. Pharmacokinetic and pharmacodynamic models of the antistaphylococcal effects of meropenem and cloxacillin in vitro and in experimental infection. Antimicrob. Agents Chemother. 41:2083-2088.
13. Michie, H. R., K. R. Manogue, D. R. Spriggs, et al. 1988. Detection of circulating tumor necrosis factor after endotoxin administration. N. Engl. J. Med. 318:1481-1486.
14. Milatovic, D. 1984. Influence of subinhibitory concentrations of antibiotics on opsonization and phagocytosis of P. aeruginosa by human polymorphonuclear leucocytes. Eur. J. Clin. Microbiol. 3:288-293.
15. Neu, H. C. 1985. Relation of structural properties of beta-lactam antibiotics to antibacterial activity. Am. J. Med. 79(Suppl. 2A):2-13.
16. Prins, J. M., M. A. van Agtmael, E. J. Kuijper, S. J. H. van Deventer, and P. Speelman. 1995. Antibiotic-induced endotoxin release in patients with gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime. J. Infect. Dis. 172:886-891.
17. Pucci, M. J., J. Boice-Sowek, R. E. Kessler, and T. J. Dougherty. 1991. Comparison of cefepime, cefpirome, and cefaclidine binding affinities for penicillin-binding proteins in Escherichia coli K-12 and Pseudomonas aeruginosa SC8329. Antimicrob. Agents Chemother. 35:2312-2317.
18. Reilly, J., A. Compagnon, P. Tournier, R. Bastin, and H. Du Buit. 1950. Les accidents du traitement des fièvres typhoides par la chloromycétine. Ann. Med. 51:598, 602, 607, 627-629, 644.
19. Sachs, L. 1982. Additional statistics for the characterization of a one dimensional frequency distribution, p. 103-106. In J. Sachs (ed.), Applied statistics, a handbook of techniques. Springer-Verlag, New York, N.Y.
20. Shenep, J. L., P. M. Flynn, F. F. Barrett, G. L. Stidham, and D. F. Westenkirchner. 1988. Serial quantitation of endotoxemia and bacteraemia during therapy for gram-negative bacterial sepsis. J. Infect. Dis. 157:565-568.
21. Suffredini, A. F., R. E. Fromm, M. M. Parker, et al. 1989. The cardiovascular response of normal humans to the administration of endotoxin. N. Engl. J. Med. 321:280-287.
22. Tesh, V. L., R. L. Duncan, Jr., and D. C. Morrison. 1986. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing. J. Immunol. 137:1329-1335.
23. Tuomanen, E., K. Gilbert, and A. Tomasz. 1986. Modulation of bacteriolysis by cooperative effects of penicillin-binding proteins 1a and 3 in Escherichia coli. Antimicrob. Agents Chemother. 30:659-663.
24. van Dissel, J. T., K. M. C. Kwappenberg, and R. van Furth. 1995. S. typhi vaccine strain Ty21A can cause a generalized infection in whole body-irradiated but not in hydrocortisone-treated mice. Scand. J. Immunol. 41:457-461.